RxDoctor Payments Data

Jane Shughart

Physician Assistant · Hagerstown, MDNPI 1457316986

Payments from drug & device makers

$754in general payments, 2019–2025

Across 41 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$138
  • GSK$86
  • Novo Nordisk$78
  • Pfizer$73
  • AstraZeneca$67
  • Eisai Inc.$63
  • plus $248 from 9 others

What the payments were for

  • Food & beverage$754100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$754 in reported general payments places this provider in the 70th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$46,171
Medicare patients
334
Services billed
633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$141,000
EliquisApixaban69$61,419
MounjaroTirzepatide31$36,704
JardianceEmpagliflozin26$34,309
XareltoRivaroxaban40$33,234
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$29,764
Tresiba Flextouch U-200Insulin Degludec18$24,812
JanuviaSitagliptin Phosphate18$21,805
Breo ElliptaFluticasone/Vilanterol34$15,035
FarxigaDapagliflozin Propanediol23$14,392
MyrbetriqMirabegron19$8,747
Divalproex Sodium14$2,809
Duloxetine Hcl63$2,263
Omeprazole126$2,155
Levothyroxine Sodium238$2,071

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$78$141,000103 claims
PfizerEliquis$73$61,41969 claims
GSKTrelegy Ellipta, Breo Ellipta$86$44,79976 claims
Lilly USA, LLCMounjaro$45$36,70431 claims
Johnson & JohnsonXarelto$21$33,23440 claims
MerckJanuvia$55$21,80518 claims
AstraZenecaFarxiga$67$14,39223 claims
AbbVieSynthroid$138$1,01424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Hagerstown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →